December 4, 2007Maxygen Licenses Dengue Vaccine Technology to Sanofi Pasteur
REDWOOD CITYMore >> October 20, 2005Maxygen Announces $14.4 Million in U.S. Government Funding to Advance HIV Vaccine Research
Redwood City, Calif., October 20, 2005 ? Maxygen, Inc. (Nasdaq: MAXY) ...
More >> September 19, 2002Maxygen Publishes Novel Approach to Regulation of the Human Immune Response
Maxygen, Inc. (Nasdaq: MAXY) announced today that its scientists have ...
More >> August 21, 2002Maxygen Receives $2.4 Million Grant to Develop Cross Protective Vaccines
Maxygen, Inc. (Nasdaq: MAXY) announced today the receipt of a $2.4 mil...
More >> July 24, 2002Maxygen Announces Appointment of Paul Spence, D.Phil.,to Senior Vice President of Research and Development, Human Therapeutics
Redwood City, Calif., July 24, 2002 – Maxygen, Inc. (Nasdaq: MAXY) ann...
More >> February 7, 2002Maxygen’s Whole Genome Shuffling Technologies Open New Product Areas in Fermentation and Vaccines
Redwood City, Calif., February 7, 2002 – Maxygen, Inc. (Nasdaq: ...
More >> November 5, 2001Maxygen and Aventis Pasteur Enter Strategic Alliance to Develop Improved Vaccines
Redwood City, Calif., and Lyon, France - November 5th, 2001- Maxygen, ...
More >> October 9, 2001Maxygen Announces Advancement of Human Therapeutics Candidates
Redwood City, Calif., October 9, 2001 – Maxygen, Inc. (Nasdaq: MAXY) a...
More >> October 3, 2001Maxygen Awarded $3.7 Million USAID Cooperative Grant to develop Malaria Vaccine
Redwood City, Calif., October 3, 2001 – Maxygen, Inc. (Nasdaq: MAXY) a...
More >> February 20, 2001Maxygen and The International AIDS Vaccine Initiative Enter Agreement to Develop Novel Vaccines Against HIV
Redwood City, Calif. and New York, NY, February 20, 2001 -- Maxygen, I...
More >> February 9, 2001Maxygen and Alk-Abello form $80 Million Strategic Alliance to Develop Next-Generation Allergy Treatments
Redwood City, Calif., USA and Hørsholm, Denmark – February 8, 2001 – M...
More >> September 15, 2000Maxygen and The Scripps Research Institute Establish Collaboration for Development of Novel HIV Therapies and Vaccines
Redwood City, Calif., September 14, 2000 - Maxygen, Inc. (Nasdaq: MAXY...
More >> July 26, 2000Maxygen Enters Into Development Program for Allergy Therapeutics with The Karolinska Institute
Redwood City, Calif., and Stockholm, Sweden, July 26, 2000 – Max...
More >> September 28, 1999Maxygen Announces $6.7 Million Grant from DARPA to Develop Aerosolized Vaccines
Redwood City, Calif., September 28, 1999 – Maxygen, Inc. announced tod...
More >>
Return to Vaccines
|
